脑部放疗，上午比下午敏感许多！4 x2 `2 t& h% C, t6 W J
1 |/ L7 P! I) B9 }9 N4 m
8 k9 B9 Y. E9 w1 FCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.7 j8 ?% e- H' C, y9 p. V
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?" O& r2 d, m, q6 v7 @
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
& A# n. u, o. Z8 g; hSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.6 {5 @& @; A/ v' B4 Q4 {% U, F- H1 E9 o5 ]
% v8 a: r: S! E$ k/ B0 X+ `0 [
Abstract, v# j$ M C, J$ @6 R4 Y% R5 o
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
. q6 B' g7 v+ g/ K8 ^2 V: l5 h: e( ~6 p
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
4 K8 R% N3 s2 C S5 [
* K# Y9 f3 W$ V- i! ZRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
- k3 _+ Q! W, ?! J+ E$ ~: A9 g* `0 ?0 j. k5 ^
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
% x$ l5 M5 U3 L7 F: [# b% a) |4 B; z1 N
|
显身卡
